FluDx Accelerator: Shape the Future of Flu Diagnostics
Join our mailing list to stay up-to-date on our latest news, events, and opportunities!
Flu Survey
Thank you for your interest in the advancement of flu research and helping us understand the resources that test developers need to innovate faster. Please proceed below to take this brief survey to share your experiences and help make a difference. Together, we can improve flu diagnostics and prevention.
Complete a brief 1-min pre-screening survey to confirm your engagement in healthcare diagnostics: here
For questions or concerns, please contact the principal investigator:
Dr. Greg Damhorst
fludx@emory.eduThe Center for the Advancement of Diagnostics for a Just Society (ADJUST Center), with the funding from Flu Lab, is launching the FluDx Accelerator – an influenza biorepository and diagnostic development accelerator, and we are seeking input from experts like you.
To ensure that this effort aligns with the real-world needs of diagnostic developers, we are conducting this brief survey and your perspective would be invaluable.
By taking the survey, your company or organization will:
- Provide feedback on challenges to developing influenza diagnostic assays
- Help guide which specimens and services will be offered as a part of the accelerator
- Be among the first notified when our specimens and services become available
- Companies with influenza diagnostics or multiplex panel diagnostics that include an influenza target (either commercialized or in development)
- Companies interested in developing influenza diagnostics
Note: This survey is not intended for developers of tests that detect only a general immune response.